EUVIMEDEUVIMED entdecken
Crossref

20 years managing malignant pleural mesothelioma: a review of our experience and the quest for the optimal prognostic marker

João Caldeira, Sofia Sousa, Ana Figueiredo, Alice Pêgo, Fernando Barata

Revista do Grupo de Estudos do Cancro do Pulmão · 2022

DOI: 10.32932/gecp.2022.02.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista do Grupo de Estudos do Cancro do Pulmão, 2022. Verfasst von João Caldeira und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Malignant pleural mesothelioma (MPM) is a rare, but aggressive incurable cancer. A variety of prognostic tools have been developed to guide clinicians and patients in the management of MPM regarding the most appropriate therapy and survival time.

Objectives

To evaluate the usefulness of the Brims’ decision tree analysis, the EORTC prognostic score, the CALGB prognostic groups, the modified Glasgow Prognostic Score (mGPS), and the LENT prognostic score in our MPM patients.

Methods

Local retrospective database analysis of patients with MPM diagnosed between 2000 and 2020. The different prognostic scores were applied and MPM group risks’ evolution was analyzed. Statistical analysis was performed with IBM® SPSS® Statistics 25.

Results

A total of 67 patients were evaluated (55 males, 82.1%). Epithelioid MPM was the commonest histological type (51 patients, 76.1%). Median overall survival (OS) was 11 months (IQR 23) and median progression free-survival (PFS) was 7 months (IQR 12.5). Survival distributions were statistically significantly different for the Brims’ and the mGPS’ groups (respectively, χ2 = 7.188, p = .027, and χ2 = 6.46, p = .04). For EORTC, CALGB and LENT score, there were not statistically significant differences in survival distributions (respectively, χ2 =.57, p = .811; χ2 = 7.978, p = .157; and χ2 = 1.23, p = .267). Brims’ model and mGPS statistically significantly predicted OS (respectively, F(1,57) = 11.1, p < 0.01, and F(1,32) = 6.846, p = .01). EORTC, CALGB and LENT failed to statistically significantly predict OS (respectively, F(1,44) = .003, p = .955; F(1.43) = .722, p = 0.4; and F(1,14) = 1.193, p = .293).

Conclusion

The small number of patients included and missing data for some parameters are limitations of our analysis. However, to our knowledge, this was the first study and the largest cohort to address MPM prognostic scores in our country. In our cohort, the Brims’ model and mGPS were useful in predicting survival. Both are simple tools with easily accessible parameters and should be considered for clinical practice.

Zitieren

APA

Caldeira, J., Sousa, S., Figueiredo, A., Pêgo, A., & Barata, F. (2022). 20 years managing malignant pleural mesothelioma: a review of our experience and the quest for the optimal prognostic marker. Revista do Grupo de Estudos do Cancro do Pulmão. https://doi.org/10.32932/gecp.2022.02.018

Vancouver

Caldeira J, Sousa S, Figueiredo A, Pêgo A, Barata F. 20 years managing malignant pleural mesothelioma: a review of our experience and the quest for the optimal prognostic marker. Revista do Grupo de Estudos do Cancro do Pulmão. 2022. doi:10.32932/gecp.2022.02.018

BibTeX
@article{Caldeira2022,
  author = {Caldeira, João and Sousa, Sofia and Figueiredo, Ana and Pêgo, Alice and Barata, Fernando},
  title = {20 years managing malignant pleural mesothelioma: a review of our experience and the quest for the optimal prognostic marker},
  journal = {Revista do Grupo de Estudos do Cancro do Pulmão},
  year = {2022},
  doi = {10.32932/gecp.2022.02.018}
}
Kostenlos starten →